Back to Search
Start Over
Efficacy and Safety of Decitabine As First-Line Therapy for Elderly Patients with Acute Myeloid Leukemia.a Real Life Multicentric Experience of the Northern Italy
- Source :
- Blood; December 2017, Vol. 130 Issue: 1, Number 1 Supplement 1 p1315-1315, 1p
- Publication Year :
- 2017
-
Abstract
- Introduction:Decitabine has been recently approved in Europe for treatment of AML patients (pts) aged more than 65 years and unfit to receive standard chemotherapy. However data on its efficacy and tolerability derive mainly from clinical trials performed in selected pts. Herein we report on a population based series of AML pts treated with decitabine and registered in observational prospective studies.
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 130
- Issue :
- 1, Number 1 Supplement 1
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs56866096
- Full Text :
- https://doi.org/10.1182/blood.V130.Suppl_1.1315.1315